Hookipa Capital Stock from 2010 to 2025

HOOK Stock  USD 1.24  0.01  0.80%   
Hookipa Pharma Capital Stock yearly trend continues to be quite stable with very little volatility. The value of Capital Stock is projected to decrease to 950.00. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals
 
Capital Stock  
First Reported
2010-12-31
Previous Quarter
1000
Current Value
950
Quarterly Volatility
2.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hookipa Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hookipa Pharma's main balance sheet or income statement drivers, such as Net Interest Income of 3.9 M, Interest Income of 3.9 M or Depreciation And Amortization of 2.9 M, as well as many indicators such as Price To Sales Ratio of 8.5, Dividend Yield of 0.0 or PTB Ratio of 0.64. Hookipa financial statements analysis is a perfect complement when working with Hookipa Pharma Valuation or Volatility modules.
  
Check out the analysis of Hookipa Pharma Correlation against competitors.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.

Latest Hookipa Pharma's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Hookipa Pharma over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Hookipa Pharma's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hookipa Pharma's overall financial position and show how it may be relating to other accounts over time.
Capital Stock10 Years Trend
Slightly volatile
   Capital Stock   
       Timeline  

Hookipa Capital Stock Regression Statistics

Arithmetic Mean2,747
Geometric Mean2,310
Coefficient Of Variation78.18
Mean Deviation1,283
Median2,000
Standard Deviation2,148
Sample Variance4.6M
Range9.1K
R-Value0.33
Mean Square Error4.4M
R-Squared0.11
Significance0.21
Slope148.90
Total Sum of Squares69.2M

Hookipa Capital Stock History

2025 950.0
2024 1000.0
202310 K
2022 5000.0
2019 3000.0

Other Fundumenentals of Hookipa Pharma

Hookipa Pharma Capital Stock component correlations

0.90.870.72-0.81-0.590.65-0.450.75-0.430.77-0.60.90.990.940.760.570.570.550.45
0.90.910.71-0.63-0.650.7-0.440.78-0.410.83-0.891.00.880.780.850.40.40.550.33
0.870.910.61-0.62-0.750.74-0.570.9-0.550.94-0.750.910.870.770.940.40.40.490.27
0.720.710.61-0.46-0.740.73-0.720.7-0.710.75-0.550.70.690.480.730.710.710.160.53
-0.81-0.63-0.62-0.460.15-0.340.03-0.40.0-0.470.26-0.63-0.83-0.88-0.45-0.66-0.66-0.41-0.46
-0.59-0.65-0.75-0.740.15-0.850.93-0.880.93-0.880.6-0.64-0.59-0.36-0.88-0.38-0.38-0.11-0.08
0.650.70.740.73-0.34-0.85-0.690.87-0.70.85-0.610.70.650.430.820.580.580.410.26
-0.45-0.44-0.57-0.720.030.93-0.69-0.761.0-0.770.37-0.43-0.43-0.19-0.77-0.39-0.390.08-0.19
0.750.780.90.7-0.4-0.880.87-0.76-0.750.96-0.650.780.740.560.940.370.370.50.35
-0.43-0.41-0.55-0.710.00.93-0.71.0-0.75-0.750.34-0.4-0.41-0.17-0.75-0.39-0.390.07-0.19
0.770.830.940.75-0.47-0.880.85-0.770.96-0.75-0.70.820.760.580.990.480.480.360.33
-0.6-0.89-0.75-0.550.260.6-0.610.37-0.650.34-0.7-0.89-0.58-0.44-0.75-0.11-0.11-0.41-0.09
0.91.00.910.7-0.63-0.640.7-0.430.78-0.40.82-0.890.880.780.840.40.40.560.33
0.990.880.870.69-0.83-0.590.65-0.430.74-0.410.76-0.580.880.950.750.580.580.510.38
0.940.780.770.48-0.88-0.360.43-0.190.56-0.170.58-0.440.780.950.560.440.440.520.28
0.760.850.940.73-0.45-0.880.82-0.770.94-0.750.99-0.750.840.750.560.450.450.350.32
0.570.40.40.71-0.66-0.380.58-0.390.37-0.390.48-0.110.40.580.440.451.00.060.52
0.570.40.40.71-0.66-0.380.58-0.390.37-0.390.48-0.110.40.580.440.451.00.060.52
0.550.550.490.16-0.41-0.110.410.080.50.070.36-0.410.560.510.520.350.060.060.53
0.450.330.270.53-0.46-0.080.26-0.190.35-0.190.33-0.090.330.380.280.320.520.520.53
Click cells to compare fundamentals

About Hookipa Pharma Financial Statements

Hookipa Pharma investors utilize fundamental indicators, such as Capital Stock, to predict how Hookipa Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Stock 1,000.00  950.00 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock:
Check out the analysis of Hookipa Pharma Correlation against competitors.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.47)
Revenue Per Share
3.505
Quarterly Revenue Growth
(0.82)
Return On Assets
(0.23)
Return On Equity
(0.62)
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.